|
KMID : 1149120220190020053
|
|
Journal of the Korean Society for Psoriasis
2022 Volume.19 No. 2 p.53 ~ p.56
|
|
|
Psoriasis Developed During the Treatment of Ulcerative Colitis with Vedolizumab
|
|
Choi Mi-Soo
Chung Ju-Hyun
Yeom Kyu-Jin
Park Byung-Cheol
Kim Myung-Hwa
|
|
|
Abstract
|
|
|
|
Ulcerative colitis (UC) is a chronic inflammatory bowel disease, and vedolizumab is the one of the treatment options of moderate-to-severe UC refractory to tumor necrosis factor- inhibitors. The development of paradoxical skin lesions, psoriasis under therapy with vedolizumab has rarely been previously reported and has never been reported in Korea. Herein, we report a case of psoriasis during vedolizumab treatment in Korea, and this case report might contribute to a better understanding of paradoxical inflammatory reactions after treatment with vedolizumab.
|
|
|
KEYWORD
|
|
|
Inflammatory bowel disease, Paradoxical, Psoriasis, Ulcerative colitis, Vedolizumab
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|